According to Zoetis's latest financial reports the company's current earnings (TTM) are $2.93 B. In 2022 the company made an earning of $2.65 B an increase over its 2021 earnings that were of $2.48 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $2.93 B | 10.54% |
2022 | $2.65 B | 6.75% |
2021 | $2.48 B | 24.65% |
2020 | $1.99 B | 10.83% |
2019 | $1.80 B | 6.57% |
2018 | $1.69 B | 10.82% |
2017 | $1.52 B | 24.19% |
2016 | $1.22 B | 125.32% |
2015 | $0.54 B | -33.54% |
2014 | $0.82 B | 18.84% |
2013 | $0.69 B | -2.82% |
2012 | $0.71 B | 80.2% |
2011 | $0.39 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pfizer PFE | $3.26 B | 11.27% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | 123.25% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | 185.94% | ๐ซ๐ท France |
Merck MRK | $3.03 B | 3.37% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $48.81 M | -98.34% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | -$39.71 M | -101.35% | ๐บ๐ธ USA |
Heska Corporation
HSKA | -$18.34 M | -100.62% | ๐บ๐ธ USA |